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 Development of atherosclerotic plaques results from 
the accumulation of cholesterol within arterial vessel walls. 
Macrophages play a critical role in this process by mediat-
ing uptake of the cholesterol-rich particle LDL, resulting 
in arterial accumulation of cholesterol. LDL uptake by 
macrophages is thought to be dependent on oxidative 
modifi cation of LDL allowing for receptor-mediated en-
docytosis of LDL to generate cholesterol-rich foam cells 
( 1 ). Recently, we identifi ed an additional mechanism of 
LDL uptake by macrophages: nonreceptor mediated fl uid-
phase pinocytosis of LDL ( 2 ). In contrast to receptor-me-
diated endocytosis, macrophage uptake of solute by 
fl uid-phase pinocytosis occurs at levels directly propor-
tional to the amount of solute within the extracellular 
fl uid. LDL is present within the intimal layer of the vessel 
wall (where foam cells develop) at high levels (0.7–2.7 
mg/ml) ( 3–5 ). Incubation of human macrophages with 
these physiological concentrations of LDL promotes foam-
cell formation by fl uid-phase pinocytosis ( 6, 7 ). Mac-
rophage fl uid-phase pinocytosis not only occurs in cell 
culture but also in plaque-resident macrophages of ath-
erosclerosis-prone mice ( 8 ). 
 Fluid-phase pinocytosis can occur by the formation of 
macropinosomes (>0.2 µm) or micropinosomes (  0.2 µm) 
( 9 ). Human macrophage colony-stimulating factor (M-CSF)-
differentiated macrophages take up LDL by fl uid-phase 
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Macrophage uptake of LDL mediated by PI3K  35
except cells were incubated with 50 ng/ml M-CSF (catalog number 
315-02, Peprotech) instead of GM-CSF, and experiments were 
performed after one week of culture. 
 Quantifi cation of macrophage cholesterol 
 Macrophages were rinsed three times in Dulbecco’s phos-
phate-buffered saline containing Ca 2+ and Mg 2+ (DPBS) (catalog 
number 21-030-CV, Mediatech), lysed with 1 ml of ultrapure wa-
ter per well, then detached with a cell scraper and collected. 
Lipid was isolated from the cell lysate using the Folch method 
( 18 ), and cholesterol was quantifi ed as previously described by 
Gamble et al. ( 19 ). Protein quantifi cation of cell lysates was mea-
sured using the Lowry method ( 20 ) with a BSA standard. 
 Visualization of neutral lipid 
 Macrophages were incubated with 4 mg/ml LDL for 24 h, 
rinsed three times with DPBS, and then fi xed at room tempera-
ture for 30 min with 4% paraformaldehyde in DPBS. Macrophages 
were rinsed three times with 3 ml of DPBS and then stained for 
15 min at room temperature with 1 ml of fi ltered Oil Red O ( 21 ). 
Oil Red O solution was prepared by dissolving Oil Red O (catalog 
number O0625, Sigma) in isopropanol to obtain a 3% solution 
(w/v). Oil Red O was diluted by adding two parts water to three 
parts Oil Red O and then fi ltered (0.45 µm). After Oil Red O 
staining, macrophages were rinsed three times with water, stained 
for 2 min with hematoxylin QS (catalog number H-3403, Vec-
tor), rinsed with water, and then coverslipped with glycerol-gela-
tin mounting media (catalog number GG1, Sigma). 
 Analysis of  125 I–LDL cell association and degradation 
 Macrophage uptake of  125 I-LDL was assessed by measuring cell-
associated and degraded  125 I-LDL according to the method of 
Goldstein et al. ( 22 ). A portion of culture media was centrifuged at 
15,000  g for 10 min, and trichloroacetic acid-soluble organic io-
dide radioactivity was measured to quantify lipoprotein degrada-
tion. Cell-associated  125 I-LDL was assessed as follows. Macrophages 
were rinsed three times with DPBS containing 0.2% BSA, followed 
by three rinses with DPBS, all at 4°C. Macrophages were dissolved 
overnight in 0.1 N NaOH at 37°C and then assayed for  125 I radioac-
tivity with a   counter.  125 I radioactivity values for wells incubated 
with  125 I-LDL without macrophages were subtracted from  125 I ra-
dioactivity values obtained for macrophages incubated with 
 125 I-LDL. Values were <1% of cell-associated  125 I-LDL. For protein 
quantifi cation, an aliquot of cell lysate was measured using the 
Lowry method ( 20 ).  125 I-LDL uptake is presented as the sum of 
cell-associated  125 I-LDL and degraded  125 I-LDL. 
 Analysis of CD11c expression by cultured macrophages 
 Macrophages were rinsed three times with DPBS and then 
fi xed 20 min with   20°C methanol. Except for fi xation, all pro-
cedures were carried out at room temperature. After fi xation, 
macrophages were rinsed three times with DPBS. For identifi ca-
tion of CD11c, macrophages were blocked with biotin/streptavi-
din (catalog number SP-2001, Vector) for 30 min, then rinsed 
three times with DPBS and incubated with 10 µg/ml biotinylated 
hamster anti-mouse CD11c (catalog number 553800, BD Pharmin-
gen) or a hamster IgG isotype control (catalog number 553952, 
BD Pharmingen). Both antibodies were diluted in DPBS. Mac-
rophages were rinsed three times in DPBS and then incubated 
with 5 µg/ml streptavidin Alexa Fluor 488 (catalog number 
S32354, Invitrogen) diluted in DPBS. After three washes with 
DPBS, macrophages were mounted with Vectashield containing 
DAPI (catalog number H-1500, Vector) and examined by fl uores-
cence microscopy. For identifi cation of CD68, macrophages were 
incubated with 10% goat serum in DPBS for 30 min, then rinsed 
macropinocytosis and micropinocytosis to become foam 
cells ( 10 ). Macrophages differentiated with human serum 
have a granulocyte-macrophage colony-stimulating factor 
(GM-CSF)-differentiated phenotype, and when activated 
with PMA, primarily take up LDL by macropinocytosis to 
become foam cells ( 6, 11 ). Similar to human macrophages, 
murine macrophages can be generated in the presence of 
M-CSF or GM-CSF ( 12 ). Murine macrophages differenti-
ated with M-CSF take up solute by macropinocytosis and 
micropinocytosis ( 13 ). In contrast to the many studies 
characterizing murine macrophages differentiated with 
M-CSF, there are few studies characterizing murine mac-
rophages differentiated with GM-CSF, and the pinocytotic 
pathways mediating uptake of solute are unknown. GM-CSF 
is found within human ( 14 ) and murine ( 15 ) atheroscle-
rotic plaques and is known to induce accumulation of lipid 
in the aorta ( 14 ). However, it is not known whether mu-
rine macrophages differentiated with GM-CSF become 
lipid-rich foam cells when incubated with LDL. 
 Previous studies show an important role for phospho-
inositide 3-kinase (PI3K) signaling in macropinosome for-
mation, although the PI3K isoform mediating this process 
has not been identifi ed ( 13 ). A major objective of this 
study was to identify the PI3K isoform mediating mac-
rophage fl uid-phase uptake of LDL. Determining this 
PI3K isoform is important for targeting fl uid-phase pino-
cytosis of LDL by macrophages. In this study, we identify 
PI3K  as a mediator of fl uid-phase pinocytosis that con-
tributes to GM-CSF-differentiated murine macrophages 
foam-cell formation through uptake of LDL. 
 MATERIALS AND METHODS 
 Culture of murine bone marrow-derived macrophages 
 Male C57BL/6 and low-density lipoprotein-null mice (C57BL/6 
background) were obtained from Jackson Laboratory. Male 
PI3K  -null (C57BL/6 background) mice were generated as 
previously described ( 16, 17 ). Femurs and tibias were isolated 
from mice, and muscle was removed. Both ends of bones were 
cut with scissors and then fl ushed with 5 ml of RPMI 1640 with a 
25-gauge needle. Cells were seeded at a density of 2 × 10 5 nucleated 
bone marrow cells/cm 2 in RPMI 1640 (catalog number 15-040-CM, 
MediaTech) containing 10% FBS (catalog number 16000-036, 
Gibco), 100 U/ml penicillin, 0.1 mg/ml streptomycin, 2 mM L-
glutamine (catalog number G6784, Sigma), and 50 ng/ml GM-CSF 
(catalog number 315-03, Peprotech) in 6-well Cellbind plates 
containing 3 ml per well (catalog number 3335, Corning). After 
a 24 h incubation at 37°C with 5% CO 2 /95% air, cells were rinsed 
three times with 3 ml RPMI 1640 to remove nonadherent cells, 
and then cultured further with 3 ml of RPMI 1640 containing 
10% FBS, 100 U/ml penicillin, 0.1 mg/ml streptomycin, 2 mM 
L-glutamine, and 50 ng/ml GM-CSF (hereafter referred to as 
complete medium). Cell culture medium was subsequently 
changed every 3 days with fresh complete medium. After 3 weeks 
in culture, experiments were performed with serum-free RPMI, 
50 ng/ml GM-CSF, and the indicated additions. GM-CSF differ-
entiation of murine bone marrow cells required 3 weeks to acquire 
a near-uniform culture of macrophages with a rounded, heavily 
vacuolated morphology. A small proportion of cells had a fl attened 
morphology. Culture of M-CSF-differentiated macrophages was 
identical to the procedure for GM-CSF-differentiated macrophages, 
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and cytokines were assayed using the Mouse Proteome Profi ler 
kit (catalog number ARY006; R and D Systems) according to the 
manufacturer’s instructions. Luminescence was detected using 
Pierce ECL Western Blotting Substrate (catalog number 32106; 
Pierce) and a 5 min exposure to Kodak BioMax MR Film (catalog 
number 895 2855; Kodak). The resulting fi lm was scanned 
and analyzed using ImageJ software. Cytokine intensities are 
presented as mean pixel density of two replicate wells per 
condition. 
 Statistical analysis 
 Data are presented as the mean ± SEM. Means were represen-
tative of three replicate wells. A paired, two-tailed  t -test was used 
for statistical comparisons. 
 RESULTS 
 Murine bone marrow-derived macrophages differenti-
ated with GM-CSF were generated from LDL receptor-
null mice. The GM-CSF-differentiated macrophages were 
round with abundant vacuoles resembling macropino-
somes, suggestive of high levels of fl uid-phase pinocytosis 
( Fig. 1 ).  GM-CSF bone marrow-derived macrophages 
three times with DPBS and incubated with 5 µg/ml of either rat 
anti-mouse CD68 (catalog number MCA1957, AbD Serotec) or 
rat IgG2 isotype control (catalog number MCA1212, AbD Sero-
tec) for 30 min. Both antibodies were diluted in DPBS. Mac-
rophages were rinsed three times in DPBS and then incubated 
with 2.5 µg/ml Alexa Fluor 594-conjugated goat anti-rat IgG (cat-
alog number A11007, Invitrogen) diluted in DPBS. After three 
washes with DPBS, macrophages were mounted with Vectashield 
containing DAPI and examined by fl uorescence microscopy. For 
fl uorescence and phase-contrast microscopic analysis, macrophages 
were imaged using an Olympus IX81 fl uorescence microscope 
with a 0.4 NA Olympus 20× objective. 
 Electron microscopic analysis of macrophages 
 To examine the general ultrastructure of macrophages, cell 
cultures were rinsed three times with DPBS. Then macrophages 
were fi xed for 1 h with 2.5% glutaraldehyde in 0.1 M cacodylate 
buffer at room temperature. Next, macrophages were dehydrated 
by exposure to increasing concentrations of ethanol (50%, 70%, 
95%, and 100%), embedded with Epon, and then polymerized 
overnight at 60°C. After polymerization, thin sections (90 nm) of 
macrophages were prepared and counterstained with saturated 
uranyl acetate and 0.4% lead citrate. Macrophage thin sections 
were then examined using a Joel 1200EX electron microscope. 
 Ultrastructural analysis of LDL uptake 
 To assess the fl uid-phase pinocytotic pathways mediating LDL 
uptake, macrophages were pretreated with or without 1 µM 
AS605240 for 1 h. Control incubations received DMSO vehicle. 
Macrophages were then incubated with 4 mg/ml LDL with or 
without 1 µM AS605240 for 10 min, fi xed at room temperature 
with 2% glutaraldehyde for 1 h, embedded in LR White resin, 
and prepared for immunogold labeling of LDL as described pre-
viously ( 23 ), except 1% dry skim milk instead of 1% BSA was used 
to block nonspecifi c staining. Thin sections were labeled fi rst 
with 10 µg/ml affi nity-purifi ed rabbit anti-human LDL antibody 
(catalog number BT-905; Biomedical Technologies, Inc.), and 
then with a 1:10 dilution of 10 nm gold-conjugated goat F(ab) 2 
anti-rabbit IgG (catalog number EM.GFAR10, Ted Pella, Inc.). 
Both primary and secondary antibodies were diluted in 0.05 M 
Tris-HCl buffer containing 0.1% dry skim milk. As a control, mac-
rophages incubated with 4 mg/ml LDL were labeled with 10 µg/ml 
affi nity-purifi ed rabbit anti-GFP antibody (catalog number 14-
6774; eBioscience). Alternatively, macrophages were incubated 
without LDL and subsequently labeled with the anti-human LDL 
antibody. All sections were counterstained with 0.4% lead citrate 
and analyzed with a Joel 1200EX electron microscope. Thirty 
random cells were observed in thin sections for untreated or 
AS605240-treated macrophages. Immunogold labels within vesi-
cles was counted, and the diameter of each pinosome containing 
LDL was measured. 
 Analysis of macrophage cytokine production 
 Macrophages were cultured in 12-well Cellbind plates in 1.5 ml 
complete medium per well for 3 weeks. Then each well contain-
ing macrophages was incubated with 0.5 ml RPMI 1640 contain-
ing 100 U/ml penicillin, 0.1 mg/ml streptomycin, 2 mM 
L-glutamine, and 50 ng/ml GM-CSF without or with 1 mg/ml 
LDL. After 24 h of incubation with or without LDL, macrophages 
were washed three times with DPBS and then incubated with 0.5 
ml RPMI 1640 containing 100 U/ ml penicillin, 0.1 mg/ml strep-
tomycin, 2 mM L-glutamine, and 50 ng/ml GM-CSF without LDL 
or serum. Culture supernatants were removed after 24 h, centri-
fuged at 1,500  g at 4°C for 10 min, and then 0.4 ml of supernatant 
was removed and stored at   20°C. Supernatants were thawed, 
 Fig.  1. GM-CSF-differentiated macrophage morphology. LDL 
receptor-null macrophages were differentiated from bone marrow 
in the presence of GM-CSF and examined by (A) phase-contrast 
microscopy or (B) electron microscopy. The scale bar for (A) light 
and (B) electron microscopic observation is 40 µm and 2 µm, re-
spectively. Arrowheads indicate macropinosomes. 
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 To determine whether GM-CSF-differentiated mac-
rophages become cholesterol-enriched foam cells when 
incubated with native LDL, we incubated macrophages 
with 0–4 mg/ml of LDL ( Fig. 3A ).  Macrophages showed 
massive, progressive accumulation of cholesterol when in-
cubated with LDL concentrations up to 4 mg/ml. Assess-
ment of macrophage-neutral lipid by Oil Red O staining 
revealed intense staining of macrophages incubated with 
LDL ( Fig. 3C ), whereas macrophages incubated without 
LDL showed no staining ( Fig. 3B ). This result shows that 
GM-CSF-differentiated murine macrophages become lipid-
enriched foam cells when incubated with native LDL. 
 We next examined the possibility that macrophages may 
increase the production of infl ammatory cytokines when 
incubated with LDL. To examine this, macrophages were 
incubated without or with 1 mg/ml LDL, and extracellular 
cytokine levels were assayed (supplementary Fig. II). Sur-
prisingly, macrophages incubated with LDL showed no 
signifi cant difference in cytokine levels compared with 
macrophages incubated without LDL. 
 To determine whether macrophages incubated with 
LDL downregulate cholesterol accumulation with time, 
we incubated macrophages with 1 mg/ml LDL for 0–24 h 
and assessed cholesterol accumulation ( Fig. 4 ).  Macrophages 
continued to accumulate LDL-derived cholesterol for the 
24 h incubation, showing that downregulation of choles-
terol accumulation does not occur within the incubation 
period examined. 
 We also determined whether removal of GM-CSF from 
the culture medium affects macrophage accumulation of 
LDL-derived cholesterol, as previous studies have shown 
that fl uid-phase pinocytosis of solute by M-CSF-differenti-
ated, mouse bone marrow-derived macrophages can be 
stimulated by M-CSF ( 29 ). Macrophages were incubated 
with LDL in the presence or absence of GM-CSF for 6 h, 
and cholesterol accumulation was assessed. Removal of 
generated from wild-type mice were morphologically simi-
lar to macrophages generated from LDL receptor-null 
mice. 
 GM-CSF is present in atherosclerotic plaques of mice 
( 15 ) and humans ( 14 ) and is known to stimulate prolifera-
tion of CD11c + CD68 + cells in atherosclerotic lesions of 
mice ( 24 ). CD68 is commonly utilized as a marker of mac-
rophages, whereas CD11c + is usually considered a specifi c 
marker of dendritic cells. However, previous studies have 
demonstrated that CD11c is expressed by some types of 
macrophages ( 25–27 ). The cells we generated from mouse 
bone marrow with GM-CSF resembled macrophages as 
described previously by Inaba et al. ( 28 ). The round mac-
rophages also resembled the round foam cells that abun-
dantly accumulate in mouse atherosclerotic lesions that 
show CD11c staining ( 24 ). Therefore, we determined 
whether our cultured GM-CSF-differentiated macrophages 
expressed CD11c. Because different macrophage pheno-
types result from differentiation of macrophage precursors 
with either with GM-CSF or M-CSF ( 12 ), we also assessed 
CD11c expression by LDL receptor-null bone marrow-
derived macrophages that were differentiated with either 
GM-CSF or M-CSF. In contrast to GM-CSF-differentiated 
macrophages, M-CSF-differentiated macrophages have an 
elongated morphology similar to human M-CSF-differenti-
ated macrophages ( 11 ). As expected, both macrophage 
phenotypes expressed the macrophage marker CD68 
( Fig. 2C , F ).  However, CD11c was expressed only by GM-CSF-
differentiated macrophages; it was not expressed by M-CSF-
differentiated macrophages ( Fig. 2B, E ). Identical results 
were obtained for macrophages differentiated from wild-type 
mice (supplementary Fig. I). These results identify a differen-
tial marker for murine GM-CSF- and M-CSF-differentiated 
macrophages and provide evidence that GM-CSF-differ-
entiated macrophages are present within atherosclerotic 
lesions of mice. 
 Fig.  2. GM-CSF-differentiated macrophages express CD11c. LDL receptor-null bone marrow cells were 
differentiated into macrophages with (A–C) GM-CSF or (D–F) M-CSF. Macrophages were immunostained 
for (B and E) CD11c or (C and F) CD68 and counterstained with DAPI. (A and D) Phase-contrast images of 
GM-CSF- or M-CSF-differentiated macrophages. Scale bar = 50 µm (applies to all micrographs). 
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for human macrophages,  125 I-LDL uptake by the mouse 
macrophages was linearly related to the concentration of 
 125 I-LDL added to cells and did not show saturation, indi-
cating that uptake occurred through fl uid-phase pinocyto-
sis and not by receptor-mediated endocytosis. Greater 
than 90% of  125 I-LDL taken up by macrophages was de-
graded.  125 I-LDL degradation could not be explained by 
extracellular degradation of  125 I-LDL because conditioned 
media from macrophages incubated with 200 µg/ml unla-
beled LDL did not produce degradation of  125 I-LDL added 
to the conditioned medium (data not shown). In contrast 
to macrophage nonsaturable uptake of  125 I-LDL, mac-
rophages incubated with increasing concentrations of  125 I-
acetylated LDL ( 125 I-AcLDL) showed saturation of  125 I-AcLDL 
uptake, indicating the expected receptor-mediated uptake 
of  125 I-AcLDL ( Fig. 5B ). These data show that macrophage 
uptake of  125 I-AcLDL occurs by binding to receptors, 
whereas native  125 I-LDL uptake occurs by fl uid-phase pino-
cytosis independently of receptors. 
 We next sought to determine whether the LDL receptor 
contributes to any signifi cant amount of macrophage uptake 
of native LDL by mouse bone marrow-derived, GM-CSF-dif-
ferentiated wild-type macrophages. To test for this possibil-
ity, we incubated wild-type macrophages with increasing 
doses of  125 I-LDL ( Fig. 5C ). Similar to LDL receptor-null 
macrophages, uptake of  125 I-LDL by wild-type macrophages 
did not saturate, and it was linearly related to the concentra-
tion of  125 I-LDL added to cells, indicating that the LDL re-
ceptor did not contribute to macrophage uptake of  125 I-LDL. 
To confi rm that macrophage uptake of LDL occurs inde-
pendently of receptors, we incubated wild-type macrophages 
with  125 I-LDL alone or  125 I-LDL and a 20-fold excess of unla-
beled LDL (supplementary Fig. IV). Macrophage uptake of 
 125 I-LDL was not signifi cantly different between groups. In 
contrast, when macrophages were incubated with  125 I-AcLDL 
and a 20-fold excess of unlabeled AcLDL,  125 I-AcLDL uptake 
levels were signifi cantly reduced compared with mac-
rophages incubated with  125 I-AcLDL only. This result con-
fi rms that macrophage uptake of unmodifi ed LDL occurs by 
fl uid-phase pinocytosis independently of receptors. 
GM-CSF from the macrophage culture medium did not 
decrease the amount of cholesterol accumulated (supple-
mentary Fig. III), indicating that macrophage LDL-derived 
cholesterol accumulation is constitutive. 
 Because the GM-CSF-differentiated macrophages showed 
morphologic evidence of macropinosomes and because 
we previously showed that human monocyte-derived mac-
rophages show fl uid-phase pinocytosis of LDL mediated 
by macropinocytosis ( 6, 7, 10 ), we anticipated that LDL 
uptake was mediated by fl uid-phase pinocytosis rather 
than receptor-mediated endocytosis, given that the LDL 
receptor could not explain the accumulation of choles-
terol. To test this idea, GM-CSF-differentiated macro-
phages were incubated with increasing concentrations 
of  125 I-LDL to assess whether receptors mediate uptake of 
 125 I-LDL ( Fig. 5A ).  Similar to what we previously showed 
 Fig.  3. Macrophage incubation with LDL leads to massive accu-
mulation of cholesterol and lipid droplets. (A) LDL receptor-null 
macrophages were incubated with increasing concentrations of 
LDL for 24 h and assessed for cholesterol accumulation. (B and C) 
LDL receptor-null macrophages were incubated (B) without or 
(C) with 4 mg/ml LDL and stained with Oil Red O to identify neu-
tral lipid. Scale bars = 40 µm. 
 Fig.  4. Accumulation of LDL-derived cholesterol by macrophages 
is progressive with time. LDL receptor-null macrophages were in-
cubated with 1 mg/ml LDL for 0–24 h and assessed for cholesterol 
accumulation. 
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LDL. To assess this,  125 I-LDL was incubated with wild-type 
macrophages in the presence or absence of AS605240, or 
with macrophages derived from PI3K  -null mice ( Fig. 6B ). 
Macrophage uptake of  125 I-LDL was inhibited 44% by 
AS605240 compared with untreated macrophages, sug-
gesting that AS605240 inhibition of PI3K  was responsible 
for the reduced uptake of  125 I-LDL. Incubation of PI3K  -
null macrophages with  125 I-LDL showed a 49% reduction 
in LDL uptake compared with wild-type macrophages, con-
fi rming that PI3K  is a mediator of LDL uptake and foam-
cell formation in GM-CSF-differentiated macrophages. 
 Because macropinocytosis requires actin polymeriza-
tion, we also determined the effect of the actin polymer-
ization inhibitor cytochalasin D on LDL-derived cholesterol 
accumulation (supplementary Fig. V). Net LDL-derived 
cholesterol accumulation was inhibited by 93% in the pres-
ence of cytochalasin D, whereas no effect of cytochalasin D 
was observed for net AcLDL-derived cholesterol accumula-
tion. This result shows that macrophage actin polymeriza-
tion is required for LDL-derived cholesterol accumulation 
but not AcLDL-derived cholesterol accumulation, and 
 Murine macrophage fl uid-phase pinocytosis previously 
has been shown to be dependent on PI3K signaling path-
ways ( 13 ), and an earlier study showed that inhibition of 
PI3K  with the PI3K  -specifi c inhibitor AS605240 resulted 
in an approximate 50% reduction in atherosclerosis ( 30 ). 
We therefore tested the effect of AS605240 on macrophage 
LDL-derived cholesterol accumulation. Wild-type mac-
rophages were incubated without LDL, with 1 mg/ml 
LDL, or with 1 mg/ml LDL and AS605240 ( Fig. 6A ). 
Macrophage net cholesterol accumulation was inhibited 
51% by AS605240, suggesting that PI3K  is a mediator of 
LDL-derived cholesterol accumulation. We assessed LDL-
derived cholesterol accumulation for GM-CSF-differenti-
ated macrophages from PI3K  -null mice to confi rm that 
PI3K  mediates LDL-derived cholesterol accumulation 
( Fig. 6A ). PI3K  -null macrophages accumulated 60% less 
cholesterol compared with wild-type macrophages, con-
fi rming our result with the PI3K  inhibitor. We next 
sought to determine whether the reduced cholesterol ac-
cumulation for AS605240-treated and PI3K  -null mac-
rophages was due to reduced fl uid-phase pinocytosis of 
 Fig.  5. Macrophage uptake of LDL is mediated by fl uid-phase pinocytosis. LDL receptor-null macrophages were incubated 24 h with in-
creasing concentrations of (A)  125 I-LDL or (B)  125 I-AcLDL for 24 h, and total  125 I-LDL uptake was assessed. (C) Wild-type macrophages were 
incubated 24 h with increasing concentrations of  125 I-LDL, and total  125 I-LDL uptake was assessed. Macrophage uptake of  125 I-LDL or 
 125 I-AcLDL represents the sum of cell-associated and degraded  125 I-lipoprotein. 
 Fig.  6. PI3K  mediates LDL-derived cholesterol 
accumulation and LDL uptake by macrophages. 
(A) Wild-type macrophages were incubated for 
24 h with 1 mg/ml LDL without or with 1 µM 
AS605240, PI3K  -null macrophages were incu-
bated for 24 h with 1 mg/ml LDL, and then choles-
terol accumulation was assessed. (B) Wild-type 
macrophages were incubated 24 h with 200 µg/ml 
 125 I-LDL without or with1 µM AS605240, PI3K  -
null macrophages were incubated 24 h with 200 
µg/ml  125 I-LDL, and then total  125 I-LDL uptake was 
assessed (i.e., sum of cell-associated and degraded 
 125 I-LDL). The percentage inhibition is indicated 
in parentheses. The basal cholesterol level was 83 
nmol/mg cell protein for untreated wild-type mac-
rophages and 78 nmol/mg cell protein for un-
treated PI3K  -null macrophages. ** P < 0.01. 
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 In this study, murine bone marrow cells were differenti-
ated into macrophages with GM-CSF. Because differentia-
tion of murine bone marrow with GM-CSF can also 
generate dendritic cells, it is important to note that 
GM-CSF-differentiated macrophages are clearly distinguish-
able from dendritic cells. In contrast to GM-CSF-differentiated 
dendritic cells that are weakly adherent to tissue culture 
plastic, GM-CSF-differentiated macrophages are strongly 
adherent ( 28 ). During macrophage differentiation, we ob-
served a small number of nonadherent dendritic cells with 
characteristic dendrites. These cells were removed by thor-
ough washing upon changing the culture medium. The 
resulting strongly adherent GM-CSF-differentiated mac-
rophages lacked the dendrite processes of the nonadher-
ent dendritic cells and, in contrast to bone marrow-derived 
dendritic cells, were heavily vacuolated ( 28 ). Thus, we 
show that our culture conditions produce macrophages, 
not dendritic cells. 
 CD11c + cells are present within nascent ( 24 ) and ad-
vanced ( 15 ) atherosclerotic plaques. These cells are 
thought to be dendritic cells due to the expression of 
CD11c, a marker regarded as specifi c for dendritic cells 
( 25 ). However, CD11c is also expressed on some types of 
macrophages ( 25–27 ), including as we have shown, the 
bone marrow-derived, GM-CSF-differentiated macrophages 
described in this study. Most CD11c + cells within early le-
sions have a rounded morphology and lack dendrites simi-
lar to the GM-CSF-differentiated macrophage phenotype 
we observed in this study, suggesting that many of these 
lesion cells are macrophages ( 24 ). 
 Inhibition of PI3K  signaling by AS605240 treatment or 
genetic deletion of PI3K  was recently found to prevent 
the development of atherosclerosis in ApoE   /   and 
LDLr   /   mice ( 30 ). AS605240 is a potent and selective in-
hibitor of PI3K  ( 32, 33 ). We show that AS605240 inhibits 
macrophage uptake of LDL and cholesterol accumulation 
  50% compared with untreated cells. As a similar reduc-
tion in LDL uptake and cholesterol accumulation was ob-
served when comparing PI3K  -null with wild-type 
macrophages, this provides further evidence that AS605240 
targets PI3K  -mediated fl uid-phase uptake of LDL. Our 
fi ndings suggest that the reduction of atherosclerosis by 
AS605240 treatment or defi ciency of PI3K  may be con-
tributed to by inhibition of macrophage uptake of LDL. 
suggests that almost all LDL uptake occurs by macropino-
cytosis. To confi rm that most macrophage uptake of LDL 
is mediated by macropinocytosis, we incubated mac-
rophages with 4 mg/ml LDL for 10 min and quantifi ed 
immunogold-labeled LDL in macropinosomes (>0.2 µm) 
and micropinosomes (  0.2 µm) by transmission electron 
microscopy ( Table 1 ).  Greater than 97% of LDL particles 
were found within macropinosomes (supplementary Fig. 
VI), and thus, essentially all LDL particles were internal-
ized within macropinosomes. Macrophages incubated 
without LDL showed no anti-LDL immunogold labeling 
(supplementary Fig. VI), consistent with most LDL being 
taken up by macropinocytosis. AS605240 treatment of 
macrophages reduced the number of LDL-containing 
macropinosomes by 38% compared with vehicle-treated 
macrophages. This resulted in a similar 41% decrease in 
the LDL particles internalized by macropinosomes. 
 DISCUSSION 
 It was previously thought that LDL uptake by murine 
macrophages occurs only by receptor-mediated uptake of 
modifi ed LDL. In this study, we report that murine GM-
CSF-differentiated macrophages take up native LDL by 
fl uid-phase pinocytosis and become lipid-rich foam cells 
independently of receptors. Macrophage uptake of LDL 
could not be attributed to receptors because uptake of 
LDL was linearly related to the concentration of LDL 
added to macrophages. Furthermore, the LDL receptor 
did not mediate macrophage uptake of LDL because wild-
type macrophages showed linear uptake of LDL, similar to 
macrophages lacking the LDL receptor. In contrast to 
macrophage fl uid-phase pinocytosis of native LDL, uptake 
of acetylated LDL showed curvilinear kinetics with respect 
to the acetylated LDL concentration added to mac-
rophages, indicating saturation of receptors. As acetylated 
LDL binds to scavenger receptors ( 31 ), native LDL uptake 
by scavenger receptors would be expected to show recep-
tor saturation similar to acetylated LDL. We found no 
evidence of receptor saturation, indicating that scaven-
ger receptors do not mediate native LDL uptake. Our 
results show that modifi cation of plasma LDL is not 
necessary for foam-cell formation in murine GM-CSF-
differentiated macrophages. 
 TABLE 1. AS605240 inhibits macrophage macropinocytosis of LDL 
Pinosome Size
Number of 
Pinosomes Containing 
Immunogold-labeled 
LDL Particles per 
Cell Section
Number of Immunogold 
LDL Particles in Pinosomes 
per Cell Section
Percentage of Immunogold-
labeled LDL Particles in 
Macro- and Micropinosomes
 AS605240  AS605240  AS605240 
  +   +   +
ma cro pinosomes 15.2 9.4 88 52 99 97
mi cro pinosomes 0.7 0.9 1 1 1 3
GM-CSF-differentiated macrophages were incubated 10 min with 4 mg/ml LDL with or without AS605240. 
LDL particles were identifi ed by anti-LDL immunogold labeling and counted. The immunogold-labeled particles 
in pinosomes were counted in 30 random cells for each condition (i.e., ±AS605240). Macropinosomes are >0.2 µm. 
Micropinosomes are 0.2 µm.
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differences exist because the macrophage yield of murine 
monocytes differentiated with GM-CSF was too low to as-
sess LDL uptake and cholesterol accumulation. 
 Murine bone marrow-derived M-CSF-differentiated 
macrophages are dependent on the presence of M-CSF for 
macropinocytosis ( 40 ). In contrast, murine bone marrow-
derived GM-CSF-differentiated macrophages showed macro-
pinocytosis of LDL independently of the presence of 
GM-CSF, as cholesterol accumulation was not decreased 
by removal of GM-CSF. Thus, macropinocytosis of LDL is 
constitutive for murine GM-CSF-differentiated macrophages. 
We did not observe downregulation of macrophage LDL-
derived cholesterol accumulation, showing that choles-
terol is able to continually accumulate within these 
macrophages during the 24 h of incubation with LDL. 
 Murine macrophage uptake of LDL by fl uid-phase pino-
cytosis is consistent with reports showing that genetic 
knockout of the scavenger receptors SRA and/or CD36, 
which mediate uptake of oxidized LDL, does not affect 
lipid accumulation and foam-cell formation in murine 
atherosclerotic plaques ( 41, 42 ). Our results help explain 
how cholesteryl ester and lipid droplets accumulate within 
arterial plaque macrophages, as macrophages incubated 
with native LDL showed massive accumulation of choles-
teryl ester and lipid droplets. Furthermore, we have identi-
fi ed PI3K  as a signaling intermediate to target for limiting 
macrophage cholesterol accumulation in atherosclerotic 
plaques.  
 The authors thank the Electron Microscopy Core Facility, 
National Heart, Lung, and Blood Institute, National Institutes 
of Health, for the use of its electron microscope. 
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